Cert Clin Haematology(SA) Phys Practice Questions - CMSA Sub-specialty Certificate In Clinical Haematology Cert Clin Haematology(SA) Phys Exam

Access More Questions

In patients with Chronic Myeloid Leukemia (CML) receiving frontline Tyrosine Kinase Inhibitor (TKI) therapy, what BCR-ABL1 transcript level on the International Scale (IS) defines an Early Molecular Response (EMR) at 3 months?

BCR-ABL1 (IS) ≤ 10% BCR-ABL1 (IS) ≤ 0.01% (MR4.0) BCR-ABL1 (IS) ≤ 0.1% (MR3.0) BCR-ABL1 (IS) ≤ 1%

Correct Answer:

BCR-ABL1 (IS) ≤ 10%

Access more questions from this quiz

Continue to Cert Clin Haematology(SA) Phys Practice Questions - CMSA Sub-specialty Certificate in Clinical Haematology Cert Clin Haematology(SA) Phys Exam for more practice questions and the full quiz experience.

Access More Questions